Maria Del Pilar Muñoz, Vice President of Sustainability and M & A, tells the Pharma Boardroom about the factors that led the company to be one of the most important Brazilian pharmaceutical companies: “We occupy a prominent position in the market thanks to the values and beliefs of our shareholders, engaging the people who build the history of Eurofarma every day and the desire to reinvest and grow, which is already part of our DNA. ”

The original material can be accessed in this link, in English, or in the version below, in Portuguese and Spanish. The yearbook on the Brazilian pharmaceutical industry market will be published in March, with worldwide circulation.